This study was carried out between July and August 2017 in malaria outpatient clinics in 1 0 4 three municipalities of Roraima, Brazil (Boa Vista, Pacaraima, and Rorainopolis). Written informed consent were obtained from all participants and blood was drawn by venipuncture. This study was approved by the Federal University of Roraima Ethical Committee (CAAE: 44055315.0.0000.5302).
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All patients attending the outpatient's health clinics for malaria screening were eligible to 1 0 9 be enrolled in the study. Enrolled patients were tested for malaria by a trained local 1 1 0 microscopist using 10% Giemsa-stained thick blood smear, and the diagnosis and and MG-LAMP assays were performed in Roraima. performed at 2,000g using a mini-centrifuge (Myfuge TM ) that was easily transported in
the field setting as opposed to a centrifuge with adjustable speeds/time.
To simplify the MG-LAMP procedure for ease-of-use in a simpler setting, a three- for 1 hour at 63ºC in a mini heat block (GeneMate, Bioexpress) to amplify the DNA. Following the 1-hour incubation, samples were removed from the heat block and allowed to cool for 15 minutes, the results were then scored by two independent readers control was included during each run using P. falciparum 3D7 DNA or nuclease free
water, respectively. water was used for each assay as a negative control. DNA samples were brought back to the malaria branch laboratory at the CDC and a 1 4 7
Plasmodium Genus-specific PET-PCR was performed, in duplicate, on all 91 samples 1 4 8
as described previously with a few modifications
22
. The reactions were each 20μL
containing 2X TaqMan Environmental Master Mix 2.0 (Applied Biosystems), 250nM of
Genus forward Primer and FAM-Genus reverse primer, and 5μL of isolated DNA. The
PET-PCR reaction was ran using an Agilent real-time PCR machine. The following
cycling parameters were used: 15 minutes initial hot-start at 95ºC followed by 45 cycles Species-specific PET-PCR was performed, in duplicate, on all samples that were positive by the genus specific PET-PCR, using species-specific primers (Table 1) . Two
duplex reactions were set up to detect P. ovale together with P. falciparum and P. forward primer, 250nM P. ovale reverse primer, 250nM of P. falciparum forward primer,
125nM of HEX-P. falciparum reverse primer, 250nM P. malariae forward primer, 250nM
FAM-P. malariae, 125nM P. vivax forward primer, 125nM HEX-P. vivax reverse primer
and 5μL of isolated DNA. Reactions were ran using the same cycling conditions as the
Genus PET-PCR. Positive controls consisting of samples with known Plasmodium 1 6 8 species and nuclease free water as a negative control were included in every run. calculating the kappa coefficients. 95% confidence intervals were calculated using MEDCALC® and GraphPad. A total of 91 patients presenting at the health clinics were enrolled in the study, (4.4%) had no previous infections and 1 (1.1%) did not provide this information. Two independent readers were used to score the MG-LAMP tests to assess whether 1 9 3 the sample was positive or negative. There was 100% agreement between the two 1 9 4
readers (Kappa=1).
9 5
Overall results of microscopy, MG-LAMP, and PET-PCR 1 9 6
A total of 91 samples were tested by microscopy, MG-LAMP and PET-PCR assay. Of
the 91 samples, 33 (36%) were positive by microscopy, 39 (43%) were positive by MG- carried out on all genus-positive samples using P. falciparum and P. vivax primers. A microscopy and PET-PCR. The sensitivity and specificity of the MG-LAMP assays and microscopy were calculated in comparison to PET-PCR used as a reference test, Microscopy detected one mixed infection, here defined as infection with both P. Out of the twenty-six enrolled patients with no malaria symptoms, five were shown to be 2 4 8 positive for malaria (asymptomatic)by the MG-LAMP and three by the PET-PCR assay.
Agreement of MG-LAMP to microscopy and PET-PCR

4 9
None of these were positive by microscopy ( Table 4) . Four of the five positive cases by
MG-LAMP were only positive at the genus level and the infecting species could not be 2 5 1 determined (Table 4) . 
Discordant Results
5 4
Seven samples were found to be discordant among the three tests (Table 5 ). Four of 2 5 5 these samples were negative by microscopy and MG-LAMP but positive by PET-PCR.
5 6
Three of these samples were only positive by PET-PCR genus test and negative by 2 5 7 species tests, while one was positive by PET-PCR P. vivax (Table 5 ). In these four a positive MG-LAMP genus test but were negative for the MG-LAMP P. falciparum and 2 6 0 P. vivax tests and by both microscopy and PET-PCR (Table 5) . The findings presented in this study demonstrate the feasibility and accuracy of MG-
LAMP as a malaria diagnostic test in a health clinic in a malaria endemic country.
6 6
Importantly our data demonstrate that MG-LAMP is sensitive enough at identifying low-2 6 7 density infections and asymptomatic patients, which is important for malaria control and missed by microscopy blood smear or standard RDT. In turn, these patients remain are sensitive, portable, and easy to use. As a more sensitive and less subjective assay 2 7 7
than microscopy and conventional RDTs, the MG-LAMP assay circumvents many of 2 7 8 these issues, providing an idea alternative molecular tool for the detection of low-density 2 7 9
infections. Previous studies have demonstrated that malaria LAMP assays in general in epidemiological surveillance studies. There were four instances where false
